PDYN

Palladyne is a story stock, not a business you can underwrite on the numbers. FY2025 revenue was just $5.25M and FELL 32.6% YoY — and the four-year history ($5.08M → $14.6M → $6.15M → $7.79M → $5.25M) shows no durable growth, only lumpy, contract-dependent swings that are now trending down. Yet the market cap is $272M, a staggering 51.8x sales. The headline 'net income of $10.0M' and 24.3x P/E are misleading: operating income was -$32.4M and the 191.4% net margin is mathematically impossible from operations, so the positive bottom line is a non-operating, non-cash artifact (fair-value/other items) sitting atop a -$481M accumulated deficit. The real engine is cash out the door — operating cash flow was -$27.6M, worsening from -$22.6M the prior year.

The 10-K states the risk in plain language: 'Our business plans require a significant amount of capital... If we require additional capital and are not able to secure new funding, we may not be able to continue our business operations.' Management funded 2025 by selling stock — $42.7M of net proceeds from common stock and warrant exercises — which is why shares outstanding jumped 32% YoY and equity ballooned +883%. That is survival by dilution, not by earning power. Cash & equivalents fell 41.6% to $18.2M; even with marketable securities inside the $52.6M current-asset base, a ~$28M annual burn means the runway is short without another raise, and each raise dilutes existing holders further.